Vigor Rehabs is establishing a gene-editing treatment to deal with poor cholesterol.
发布者：BY MARKETWIRE，转转请注明出处：https://robotalks.cn/media-eli-lilly-nears-billion-dollar-acquisition-of-gene-editing-biotech/
Media: Eli Lilly nears billion-dollar acquisition of gene editing biotech
赞 (0)
关于作者
AbbVie cancer drug fails in phase 3 combination trial
上一篇
18 6 月, 2025 1:18 上午
Roche to test Parkinson’s drug in phase 3 trial despite previous study failures
下一篇
18 6 月, 2025 1:18 上午
相关推荐
-
X Square Robot Secures $140 Million in Series A++ Funding
With leading technology firms such as Alibaba Team and Meituan currently backing it from previous rounds, X Square Robotic has actually shown engaging design capacities and item po…
-
Widebody Aircraft MRO Business Research Report 2024-2030: Enhanced Real-time Monitoring Systems Strengthen Business Case – ResearchAndMarkets.com
DUBLIN–( COMPANY CORD)– The “Widebody Airplane MRO – International Strategic Organization Record” record has actually been included in ResearchAndMark…
-
Washing machine filter captures microfibers as small as 20 micrometers in size
A solitary washing tons having artificial garments can launch hundreds of plastic microfibers from nylon, acrylic and polyester products. Laboratory screening of an SA-made cleanin…
-
Apple’s push for automation: Airlifts, tariffs, and the future of iPhone manufacturing
As geopolitical tensions continue to reshape global trade, Apple finds itself re-engineering not just iPhones but its entire production model. Reports that the company recently air…
